Drugs / Bethametasone
Bethametasone
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01915979 Comparator | Feb 2014 → May 2015 | rotator cuff syndrome | Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02865746 Comparator | Jul 2004 → May 2005 | — | Federal University of the Valleys of Jequitinhonha and Mucuri | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bethametasone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02865746 ↗ |
| Known as | betamethasone | “The objective of this randomized double-blind study was to evaluate the effect of betamethasone in the control of postoperative pain in patients undergoing endodontic treatment.” NCT02865746 ↗ |
| Known as | betamethasone disodium phosphate | “Active Comparator: betamethasone disodium phosphate at a concentration of 4 mg / ml - dosage of 0.05 mg / kg” NCT02865746 ↗ |
| Known as | Celestone cronodose | “Drug: Celestone cronodose (Bethametasone)” NCT01915979 ↗ |
| Modality | Other / unclassified | “systemic administration of corticosteroids” NCT02865746 ↗ |
| Route | Other | “This group will receive a total of three intraarticular injections of 2ml.” NCT01915979 ↗ |